Status:
COMPLETED
Market Penetration of Laser Therapy in Venous Surgery: Ziekenhuis Oost-Limburg - Ziekenhuis Maas En Kempen Center Experience
Lead Sponsor:
Duomed
Conditions:
Varicose Veins
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this registry is to evaluate the indication for EndoVenous Laser Ablation (EVLA) therapy. Can this be enhanced? What are the reasons for not using the laser? Therefore, this study aims to ...
Eligibility Criteria
Inclusion
- Patient is at least 18 years old.
- Patient must sign and date the informed consent form prior to treatment.
- Presence of unilateral or bilateral primary or recurrent symptomatic varicose veins (CEAP grade ≥ C2).
- Patient has an insufficient Great Saphenous Vein (GSV), Anterior Accessory Saphenous Vein (AASV) and/or Small Saphenous Vein (SSV), with venous symptoms (valve incompetence).
Exclusion
- Current deep vein thrombosis.
- Acute superficial thrombosis.
- Pregnancy.
- Coagulopathy or bleeding disorders.
- Contraindications to the use of general or regional anesthesia.
Key Trial Info
Start Date :
March 15 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 8 2023
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT03856814
Start Date
March 15 2019
End Date
November 8 2023
Last Update
September 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ziekenhuis Oost-Limburg (Sint-Jan,Genk; Sint-Barbara,Lanaken; ZMK,Maaseik)
Genk, Limburg, Belgium, 3600